CLINICAL_TRIALS
withdrawal
· 2023-09-26
Clinical Trial Update: Dexamethasone Administered Via the Epidural Catheter as an Adjunct in Patients Undergoing Cesarean Delivery [Phase 4]
Summary
A Phase 4 trial evaluating dexamethasone via epidural catheter as an adjunct in cesarean delivery has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Henry Ford Health System | Conditions: Post Operative Pain | Phase 4 | Status: WITHDRAWN